# Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy

> **NCT00093132** · PHASE1,PHASE2 · TERMINATED · sponsor: **Agennix** · enrollment: 20 (actual)

## Conditions studied

- Carcinoma, Non-small Cell Lung
- Lung Cancer

## Interventions

- **DRUG:** Satraplatin

## Key facts

- **NCT ID:** NCT00093132
- **Lead sponsor:** Agennix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-08
- **Primary completion:** 2009-01
- **Final completion:** 2009-02
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Sponsor decided to discontinue study drug development.
- **Last updated:** 2012-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00093132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00093132, "Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00093132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*